Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 304

1.

Mouse induced pluripotent stem cells.

Geoghegan E, Byrnes L.

Int J Dev Biol. 2008;52(8):1015-22. doi: 10.1387/ijdb.082640eg. Review.

2.

Generation of mouse induced pluripotent stem cells without viral vectors.

Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S.

Science. 2008 Nov 7;322(5903):949-53. doi: 10.1126/science.1164270. Epub 2008 Oct 9.

3.

More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.

Huang J, Chen T, Liu X, Jiang J, Li J, Li D, Liu XS, Li W, Kang J, Pei G.

Cell Res. 2009 Oct;19(10):1127-38. doi: 10.1038/cr.2009.106. Epub 2009 Sep 8.

PMID:
19736564
4.

Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.

Kim JB, Zaehres H, Wu G, Gentile L, Ko K, Sebastiano V, Araúzo-Bravo MJ, Ruau D, Han DW, Zenke M, Schöler HR.

Nature. 2008 Jul 31;454(7204):646-50. doi: 10.1038/nature07061. Epub 2008 Jun 29.

PMID:
18594515
5.

Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53.

Takenaka C, Nishishita N, Takada N, Jakt LM, Kawamata S.

Exp Hematol. 2010 Feb;38(2):154-62. doi: 10.1016/j.exphem.2009.11.003. Epub 2009 Nov 14.

PMID:
19922768
6.

Yamanaka factors critically regulate the developmental signaling network in mouse embryonic stem cells.

Liu X, Huang J, Chen T, Wang Y, Xin S, Li J, Pei G, Kang J.

Cell Res. 2008 Dec;18(12):1177-89. doi: 10.1038/cr.2008.309.

PMID:
19030024
7.

Fibroblast-derived induced pluripotent stem cells show no common retroviral vector insertions.

Varas F, Stadtfeld M, de Andres-Aguayo L, Maherali N, di Tullio A, Pantano L, Notredame C, Hochedlinger K, Graf T.

Stem Cells. 2009 Feb;27(2):300-6. doi: 10.1634/stemcells.2008-0696.

8.

Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells.

Meissner A, Wernig M, Jaenisch R.

Nat Biotechnol. 2007 Oct;25(10):1177-81. Epub 2007 Aug 27.

PMID:
17724450
9.

Induction of pluripotency: from mouse to human.

Zaehres H, Schöler HR.

Cell. 2007 Nov 30;131(5):834-5.

10.

Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.

Zhou W, Freed CR.

Stem Cells. 2009 Nov;27(11):2667-74. doi: 10.1002/stem.201.

11.

Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin.

Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, Cassady JP, Beard C, Brambrink T, Wu LC, Townes TM, Jaenisch R.

Science. 2007 Dec 21;318(5858):1920-3. Epub 2007 Dec 6.

12.

Induced pluripotency with endogenous and inducible genes.

Duinsbergen D, Eriksson M, 't Hoen PA, Frisén J, Mikkers H.

Exp Cell Res. 2008 Oct 15;314(17):3255-63. doi: 10.1016/j.yexcr.2008.06.024. Epub 2008 Jul 9.

PMID:
18656469
13.

Accelerated generation of human induced pluripotent stem cells with retroviral transduction and chemical inhibitors under physiological hypoxia.

Shimada H, Hashimoto Y, Nakada A, Shigeno K, Nakamura T.

Biochem Biophys Res Commun. 2012 Jan 13;417(2):659-64. doi: 10.1016/j.bbrc.2011.11.111. Epub 2011 Dec 8.

PMID:
22172948
14.

Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes.

Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, Vassena R, Bilić J, Pekarik V, Tiscornia G, Edel M, Boué S, Izpisúa Belmonte JC.

Nat Biotechnol. 2008 Nov;26(11):1276-84. doi: 10.1038/nbt.1503. Epub 2008 Oct 17.

PMID:
18931654
15.

[Induction and characterization of induced pluripotent stem (iPS) cells: a review].

Cheng D, Lei L, Lu Z, Li Z, Wang H.

Sheng Wu Gong Cheng Xue Bao. 2010 Apr;26(4):421-30. Review. Chinese.

PMID:
20575428
16.

Emerging methods for preparing iPS cells.

Miyazaki S, Yamamoto H, Miyoshi N, Takahashi H, Suzuki Y, Haraguchi N, Ishii H, Doki Y, Mori M.

Jpn J Clin Oncol. 2012 Sep;42(9):773-9. doi: 10.1093/jjco/hys108. Epub 2012 Jul 23. Review.

PMID:
22826352
17.

Endogenous KLF4 expression in human fetal endothelial cells allows for reprogramming to pluripotency with just OCT3/4 and SOX2--brief report.

Ho PJ, Yen ML, Lin JD, Chen LS, Hu HI, Yeh CK, Peng CY, Lin CY, Yet SF, Yen BL.

Arterioscler Thromb Vasc Biol. 2010 Oct;30(10):1905-7. doi: 10.1161/ATVBAHA.110.206540. Epub 2010 Aug 5.

PMID:
20689077
18.

Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.

Tsai SY, Clavel C, Kim S, Ang YS, Grisanti L, Lee DF, Kelley K, Rendl M.

Stem Cells. 2010 Feb;28(2):221-8. doi: 10.1002/stem.281.

19.

Direct reprogramming 101.

Takahashi K.

Dev Growth Differ. 2010 Apr;52(3):319-33. doi: 10.1111/j.1440-169X.2010.01169.x. Epub 2010 Mar 7. Review.

PMID:
20298260
20.

[Induced pluripotent stem cells].

Shevchenko AI, Medvedev SP, Mazurok NA, Zakiian SM.

Genetika. 2009 Feb;45(2):160-8. Review. Russian.

PMID:
19334609

Supplemental Content

Support Center